News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Thermo Fisher Scientific (TMO) Completes CE-IVD Registration Of Its QuantStudio 5 Dx System For In Vitro Diagnostic Use In Europe



7/31/2017 12:38:28 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

SAN DIEGO, July 31, 2017 /PRNewswire/ -- AACC -- Thermo Fisher Scientific today announced the successful CE-IVD registration of its QuantStudio 5 Dx Real-Time PCR System for sale in European countries. The platform provides European customers with modern and user-friendly instrument that is designed to easily integrate into their existing diagnostic workflow. The product will be on exhibit in booth #4039 during the 2017 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, being held July 31 August 3 at the San Diego Convention Center.

 (PRNewsfoto/Thermo Fisher Scientific Inc.)

"Many diagnostic qPCR instruments on the market today are dated. These older platforms do not leverage key advances in design that improve accuracy and the user experience", said Will Geist, vice president and general manager of qPCR for Thermo Fisher. "Today's molecular diagnostic laboratories and developers require high-performing qPCR systems that can be seamlessly adopted into their in-vitro diagnostic (IVD) work flow."

The QuantStudio 5 Dx has been designed to deliver an enhanced user experience with multi-modal software, enabling users to operate the instrument in either test-development, research use only (RUO) mode, or IVD mode. This modern, affordable, easy-to-use qPCR system lends itself ideally to clinics, hospitals and diagnostic test developers performing molecular biology testing using quantitative PCR.

The platform has seen strong adoption since its introduction. Siemens Healthineers and Thermo Fisher announced a strategic agreement focused on incorporating the QuantStudio 5 System into Siemens' Atellica® MDX 160 Molecular System to provide more flexibility and customization to its laboratory workflow. In addition, Seegene Inc. and Thermo Fisher jointly announced a collaborative partnership to seek clearance from the U.S. Food and Drug Administration (FDA) for Seegene's Allplex diagnostic assay portfolio on the QuantStudio 5 System, for which Thermo Fisher is seeking clearance in parallel.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Media Contact Information:
Mauricio Minotta, Thermo Fisher Scientific
+1 760 929 2456
+1 760 805 5266 (mobile)
mauricio.minotta@thermofisher.com

View original content with multimedia:http://www.prnewswire.com/news-releases/thermo-fisher-scientific-completes-ce-ivd-registration-of-its-quantstudio-5-dx-system-for-in-vitro-diagnostic-use-in-europe-300496356.html

SOURCE Thermo Fisher Scientific Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES